Germany· DE-A57-4283d18f549186a6

Temozolomid Fair-Med Healthcare

A temozolomide product containing temozolomide, registered in Germany by Fairmed Healthcare Gmbh. The same ATC class is registered in 17 of our 19 countries.

ATC L01AX03

Checked against EMA Article 57 (European Union) on September 30, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about temozolomideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Temozolomide is registered in 17 of 19 countries.

Countries holding a registration under ATC L01AX03 (temozolomide), each read from that country’s own register.

This record: Germany, from EMA Article 57 (European Union)
10 of them publish a price we can compare per daily dose

Search temozolomide products by name

Temozolomide · ATC L01AX03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of temozolomide costs, country by country.

Normalised to the WHO defined daily dose (65 mg), so markets compare like for like.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Temozolomide · price per daily dose (65 mg)

USD · FX 28 Sept 2026

IT Italy$43.87
CH Switzerland$34.49

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

EMA Article 57 (European Union)

Active substance: Temozolomide
Manufacturer: Fairmed Healthcare Gmbh
Country: Germany (DE)
ATC code: L01AX03
ATC class: Temozolomide
Defined daily dose: 65 mg, O
Reimbursed: Not published by this register
Source register: EMA Article 57 (European Union)
Last checked: September 30, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

354 interactions on record for temozolomide.

Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check temozolomide against other medicines How interaction checks work

Temozolomide · interactions on record

354 records

33 severe
103 moderate
16 minor
202 info

Most severe, free to view

MipomersenC10AX11severe
LomitapideC10AX12severe
CladribineL01BB04severe
PexidartinibL01EX15severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Temozolomide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All temozolomide products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

Cyprus · Advecit, Ridoca
Czechia · Temozolomide Glenmark
Denmark · Temozolomid Fair-Med, Temozolomid Stada
Estonia · Blastomat
Finland · Temozolomid Ratiopharm
France · Kimozo, Temozolomide Viatris
United Kingdom (Northern Ireland) · Temozolomide, Temozolomide Crescent Pharma
Greece · Ridoca
Croatia · Temazol, Temozolomid Pgf Pharma
Hungary · Temozolomide Pharmacenter
Ireland · Temozolomide Clonmel, Temozolomide Fair-Med
Iceland · Temodal, Temomedac
Liechtenstein · Temodal, Temomedac
Lithuania · Blastomat
Latvia · Blastomat
Malta · Temozolomide Clonmel 100mg Hard Capsules, Temozolomide Clonmel 140mg Hard Capsules
Netherlands · Blastomat, Nogron
Norway · Temodal, Temomedac
Poland · Temozolomide Fair-Med, Temozolomide Glenmark
Portugal · Temozolomida, Temozolomide
Romania · Temozolomidă Hf
Sweden · Temozolomid Stada, Temozolomide Pgf Pharma
Slovakia · Temostad

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/145cf9d2-e4e0-41fd-8a41-971eead84a8d
GET /v1/drugs/145cf9d2-e4e0-41fd-8a41-971eead84a8d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "pzn": null,
  "route": "Oral Use",
  "source": "ema_art57_de",
  "ma_number": null,
  "substance": "Temozolomide",
  "atc_from_source": null,
  "authorisation_country": "Germany"
}

API reference MCP server Plans

See everything about temozolomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console